Talks will include: 

1) OCT biomarkers in DMO - what adds value in clinical-decision making? - Christiana Dinah, Consultant Ophthalmologist and medical retina specialist, London 

2) Debate: When should you switch treatment in DMO? versus late  - Deepali Varma, Consultant Ophthalmologist and medical retina specialist, Sunderland & Phil Burgess, Consultant Ophthalmologist and medical retina specialist, Liverpool